Matches in Wikidata for { <http://www.wikidata.org/entity/Q96613624> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q96613624 description "2020 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q96613624 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96613624 description "scientific article published on 10 June 2020" @default.
- Q96613624 description "wetenschappelijk artikel" @default.
- Q96613624 description "наукова стаття, опублікована 10 червня 2020" @default.
- Q96613624 name "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 name "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 type Item @default.
- Q96613624 label "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 label "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 prefLabel "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 prefLabel "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 P1433 Q96613624-FCEB06CE-579E-4A68-808C-C38F7FE27C0D @default.
- Q96613624 P1476 Q96613624-31108A33-D35D-48DA-A53B-4F5920C82712 @default.
- Q96613624 P2093 Q96613624-44366274-65E9-4B66-85BE-6504A19800D5 @default.
- Q96613624 P2093 Q96613624-736622E5-E310-487C-BE19-E65D9CA03EC1 @default.
- Q96613624 P2093 Q96613624-B07595C1-FBCD-4ABF-9205-01E64167E474 @default.
- Q96613624 P2093 Q96613624-C83C9EB1-5D5E-42D7-BEB2-9D26207D6DDB @default.
- Q96613624 P2093 Q96613624-E17AD398-92EB-483F-B0BB-F179035CD3B8 @default.
- Q96613624 P304 Q96613624-AF0AC54B-83F6-4D72-9184-36AB01F0F9C9 @default.
- Q96613624 P31 Q96613624-5EEB2706-4A7B-4FE9-BD61-40E17FCA50AB @default.
- Q96613624 P356 Q96613624-4410D244-DDDC-448F-8C5E-84986F10AA25 @default.
- Q96613624 P478 Q96613624-30C825BA-1AA0-4386-AAD4-2CD5D5B839D8 @default.
- Q96613624 P50 Q96613624-5595ACCE-EAF5-4E3F-A77F-F0000A754874 @default.
- Q96613624 P577 Q96613624-E702B2C2-1CAE-4DF5-9782-6969FC0B8BA4 @default.
- Q96613624 P698 Q96613624-144A0967-5F7C-4078-B5CE-CD65A9F1FC6E @default.
- Q96613624 P921 Q96613624-98E10D1B-D56C-4B05-92D3-5E84D205D7CE @default.
- Q96613624 P356 J.LEUKRES.2020.106401 @default.
- Q96613624 P698 32562875 @default.
- Q96613624 P1433 Q15716445 @default.
- Q96613624 P1476 "The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy" @default.
- Q96613624 P2093 "Emili Montserrat" @default.
- Q96613624 P2093 "Julio Delgado" @default.
- Q96613624 P2093 "Luciano Levato" @default.
- Q96613624 P2093 "Mirella Lentini" @default.
- Q96613624 P2093 "Tycho S Baumann" @default.
- Q96613624 P304 "106401" @default.
- Q96613624 P31 Q13442814 @default.
- Q96613624 P356 "10.1016/J.LEUKRES.2020.106401" @default.
- Q96613624 P478 "95" @default.
- Q96613624 P50 Q59660152 @default.
- Q96613624 P577 "2020-06-10T00:00:00Z" @default.
- Q96613624 P698 "32562875" @default.
- Q96613624 P921 Q5984881 @default.